-
Medical Research Council
-
World Health Organization
-
Health Systems Trust
-
UNAIDS
-
The Global Forum on MSM & HIV (MSMGF)
Standard Treatment Guidelines and Essential Drugs List Primary Health Care
These initial products cover common health problems and drugs lists at secondary and tertiary hospital level. There were problem areas, where common conditions arise by concentration and are complicated, problematic, essentially rare, expensive to diagnose and to treat and require complicated procedures. Such conditions, e.g. onco-therapy, dialysis, transplantation, and HIV/AIDS, require special mention and attention at a different level. A next stage would be to consider the appointment of panels of experts, guided by health authority policies, to develop protocols, covering all aspects, including cost implications, palliation, treatment, prognosis, selection criteria and mechanisms of funding.
Hopefully the completed initial step will facilitate the development of rational prescribing and dispensing, eliminate wastage, encourage research and critical evaluation and facilitate equity in health care.
| Attachment | Size |
|---|---|
| EDL-PHC | 706.57 KB |
| EDL-Adult | 668.04 KB |
| EDL-Paed | 764.68 KB |
Related Content
- Preventable disease costing lives
- On the way down
- Leading Organisations Call For Recognition Of Palliative Care And Pain Treatment As Human Rights
- WHO takes major steps to make HIV treatment accessible: Treatment Guidelines and AIDS Medicines List Announced by WHO
- Professional Roles and ARV provision
- Living until you die
- GlaxoSmithKline responds to Oxfam's Campaign
- Window on the world of family medicine
- Health systems: orphan of research
- Back to Basics for Health Care
- Scaling-up treatment for HIV in South Africa - a way forward.
- Essential Drugs List Programme
- Is democracy good for people's health? A South African perspective
- Ms Nozizwe Madlala-Routledge, keynote address at Ugu District, HIV and AIDS
- Measuring the move towards equity - from the site of service delivery



